Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02744300 · ClinicalTrials.gov registry record · NA
Balance After Baby Intervention for Women With Recent Gestational Diabetes
A NA study of Gestational Diabetes Mellitus, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT02744300: Completed NA study of Gestational Diabetes Mellitus, sponsored by Brigham and Women's Hospital.
NCT02744300 is a NA study of Gestational Diabetes Mellitus that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 180 participants, below the 408-participant average among 16 other Gestational Diabetes Mellitus trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02744300, a NA study of Gestational Diabetes Mellitus, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
Women with a history of gestational diabetes mellitus (GDM) have an increased risk of developing type 2 diabetes later in life. In our 2012 pilot study we created and tested a web-based lifestyle intervention program adapted from the NIH sponsored Diabetes Prevention Program (DPP), modified specifically for women with a recent history of GDM. This program, delivered in the first year postpartum, encouraged weight loss, dietary changes, and physical activity. The purpose of the current study, called Balance After Baby Intervention 2 (BABI-2), is to study a larger group of women with two years of follow-up. We will assess whether women assigned to the intervention group lose more weight and decrease their risk factors for type 2 diabetes. Participants assigned to the BAB lifestyle intervention will receive support from a lifestyle coach and gain access to a website with online presentations that contain healthy eating and physical activity educational tips. Participants assigned to the post-GDM follow-up group will have access to a website containing links to information about diabetes prevention.
Primary Outcome
Postpartum weight loss will be measured from 6 weeks postpartum to 12 months postpartum.
Conditions Studied
Interventions
- BEHAVIORAL BABI-2 Lifestyle Intervention
Study Locations (1)
Colorado
- University of Colorado Denver - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2016-09 |
| Est. Completion | 2019-07-29 |
| Phase | NA |
What the finished NCT02744300 record still lists
NCT02744300 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 408-participant average among 16 other Gestational Diabetes Mellitus trials with a reported enrollment target (56% lower).
The record links to 1 condition, with Gestational Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which BABI-2 Lifestyle Intervention is the first listed.
NCT02744300 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT02744300 about?
NCT02744300 is a clinical study titled "Balance After Baby Intervention for Women With Recent Gestational Diabetes". Women with a history of gestational diabetes mellitus (GDM) have an increased risk of developing type 2 diabetes later in life. In our 2012 pilot study we created and tested a web-based lifestyle intervention program adapted from the NIH sponsored Diabetes Prevention Program (DPP), modified specific...
What is the current status of trial NCT02744300?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2016-09. Estimated completion is 2019-07-29.
What conditions does trial NCT02744300 study?
This clinical trial studies the following conditions: Gestational Diabetes Mellitus.
What interventions are being tested in trial NCT02744300?
The interventions under investigation include: BABI-2 Lifestyle Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02744300?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02744300 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02744300's enrollment target sits among peer trials
180 10th of 16 higher than 6 of 16 other Gestational Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gestational Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Strawberry Candy Twists as an Alternative Screen for Gestational Diabetes: A Prospective Trial
RECRUITING · NA
-
A Shared Decision Making Intervention for Diabetes Prevention in Women With a History of Gestational Diabetes Mellitus
ACTIVE NOT RECRUITING · NA
-
Assessing the Effectiveness of a Weight Watchers-based Lifestyle Intervention for the Primary Prevention of Type 2 Diabetes
COMPLETED · NA
-
Supporting American Indian/Alaska Native Mothers and Daughters in Reducing Gestational Diabetes Risk
COMPLETED · NA
-
Intrapartum Glycemic Control With Insulin Infusion Versus Rotating Fluids
COMPLETED · NA
-
Evaluating the Feasibility of Using M-Health to Improve Serum Glucose Logs
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia